Mark Antenucci, D.P.M
Podiatrist in Roswell, New Mexico.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 10,602 in Podiatrist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Mark Antenucci, D.P.M reported a CMS MIPS final score of 0/100 - below the 83.5 national average - and filed 172 Medicare Part D claims in 2024.
- 0/100
- MIPS score · -83 vs avg
- 172
- Part D claims, 2024
- ≥0th
- pct among measured MIPS (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Mark Antenucci, D.P.M
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1760490759), first enumerated 08/04/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 172 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 0/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1760490759 · Podiatrist
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-LOW · RX-LIGHT · BOOK-THIN · PHOTO-FINISH
- NPI-10 1760490759
- ENUM-LEGACY 2006
- TAX-MID 11K Podiatrist
- MIPS-LOW 0/100
- RX-LIGHT 172
- BOOK-THIN 64 in New Mexico
- PHOTO-FINISH Keith Arbuckle · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Antenucci · this… 0
Antenucci · this provider
0 MIPS pts
- Robert Buckenber… 0
Robert Buckenberger
0 MIPS pts
- Keith Arbuckle ·… 0
Keith Arbuckle
0 MIPS pts
- David Bates · near 0
David Bates
0 MIPS pts
- James Bowman · n… 0
James Bowman
0 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Mark Antenucci, D.P.M's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
0 ≥ 0th percentile 0% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Mark Antenucci, D.P.M sits
This provider among podiatrist peers
Across the 2,362 podiatrist providers who report both Medicare Part D prescribing and a MIPS quality score, Mark Antenucci, D.P.M writes more Part D claims than 42% of them and scores higher on MIPS quality than 0% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one podiatrist peer from a representative sample of 60; the gold marker is Mark Antenucci, D.P.M. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
What does the federal data show about Mark Antenucci, D.P.M?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in New Mexico
How Podiatrist compares to other specialties among New Mexico providers
Podiatrist ranks #81 among New Mexico's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the New Mexico provider total, by primary NUCC taxonomy. The highlighted bar is Podiatrist; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Mark Antenucci, D.P.M's 2023 MIPS final score plotted against the Podiatrist national average
- MIPS Final Score
- 0/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Specialty volume Podiatrist US NPIs
0/100 MIPS final score - 83.5 pts below the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Podiatrist. Quality dim: 0.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1760490759 |
|---|---|
| Specialty | Podiatrist |
| Credentials | D.P.M |
| Gender | Male |
| NPI Issued | 08/04/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Mark Antenucci, D.P.M's current license status, disciplinary history, and board certifications with the New Mexico Medical Board in New Mexico before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1760490759 is the unique 10-digit identifier CMS uses to link Antenucci across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
Prescribing Breakdown
- 30-Day Fills
- 206.4
- Total Day Supply
- 4,939
- Brand Drug Cost
- $0
- Generic Drug Cost
- $2K
Patient Demographics
- Average Patient Age
- 69.0 years
- Avg HCC Risk Score
- 1.46
- Gender Split
- 45% female / 55% male
- Age Distribution
- <65: 16, 65-74: 29, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Mark Antenucci, D.P.M prescribes most
Top Medicare Part D drugs by claim count, 2024
- Gabapentin
Gabapentin
74 claims
- Gentamicin Sulfate
Gentamicin Sulfate
39 claims
- Pregabalin 11
Pregabalin
11 claims
| Drug | Claims |
|---|---|
| Gabapentin | 74 |
| Gentamicin Sulfate | 39 |
| Pregabalin | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Podiatrist Overview
How Mark Antenucci, D.P.M fits within the Podiatrist landscape nationally.
Mark Antenucci, D.P.M's 172 claims are below the specialty average of 320.
Nationwide Podiatrist peers with similar MIPS or enrollment year
Two federal-record peer sets for Antenucci, both outside New Mexico so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (0 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Podiatrist Providers in New Mexico
Other clinicians with the same primary specialty enrolled in New Mexico, drawn from the same CMS NPPES roster as Antenucci.
One of 64 Podiatrist providers enrolled in New Mexico, 5 are shown here.
Compare Podiatrist nationally: see state-by-state distribution →
Frequently Asked Questions
What is Mark Antenucci, D.P.M's specialty? ▼
How much does Mark Antenucci, D.P.M prescribe under Medicare Part D? ▼
What is Mark Antenucci, D.P.M's Medicare quality score? ▼
Where is Mark Antenucci, D.P.M located? ▼
What is Mark Antenucci, D.P.M's NPI number? ▼
How many Podiatrist providers are there in the US? ▼
What drugs does Mark Antenucci, D.P.M prescribe most often? ▼
Does Mark Antenucci, D.P.M accept Medicare? ▼
How can I verify Mark Antenucci, D.P.M's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.